Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.
Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.
Michael Ganio, PharmD, MS, BCSCP, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and a Board Certified Sterile Compounding Pharmacist (BCSCP).
Tom Kraus, JD, MHS serves as the vice president of government relations for ASHP. Kraus previously served as the deputy staff director of health on the U.S. Senate Committee on Health, Education, Labor and Pensions under Senators Edward Kennedy and Tom Harkin, where he was instrumental in the passage of key legislation, including Food and Drug Administration (FDA) drug and food safety reforms and user fee legislation, the American Recovery and Reinvestment Act, and the Affordable Care Act. Following his time on Capitol Hill, he joined the FDA, where he served as Chief of Staff and Associate FDA Commissioner for Legislation.